Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : CTMX save search
CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 1.21%
H: 0.48%
C: -1.44%
cx-2051 first tumors therapeutics advanced study
CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
Published: 2024-04-03 (Crawled : 12:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: -0.47%
H: 2.35%
C: 0.94%
probody candidate t-cell collaboration therapeutics
CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: -1.76%
H: 3.59%
C: 0.45%
therapeutics
CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas - March 18, 2024
Published: 2024-03-18 (Crawled : 16:00) - biospace.com/
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 0.97%
H: 0.48%
C: -3.35%
probody t-cell collaboration therapeutics milestone
CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 0.97%
H: 0.48%
C: -3.35%
probody collaboration therapeutics milestone
CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
Published: 2024-03-11 (Crawled : 20:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: -19.52%
H: 8.87%
C: 6.44%
business update therapeutics financial results
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
Published: 2024-03-04 (Crawled : 15:00) - biospace.com/
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 1.89%
H: 5.74%
C: 1.48%
report year therapeutics financial results
CytomX Therapeutics to Present at Upcoming March Investor Conferences
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 0.61%
H: 46.99%
C: 35.54%
therapeutics
CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b
Published: 2024-01-24 (Crawled : 13:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 2.48%
H: 0.0%
C: -7.27%
cx-2051 probody fda drug antibody clearance therapeutics
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference
Published: 2024-01-12 (Crawled : 13:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 0.0%
H: 2.96%
C: 2.37%
conference therapeutics
CytomX Therapeutics Outlines 2024 Company Priorities and Milestones
Published: 2024-01-04 (Crawled : 13:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: -5.49%
company therapeutics
CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-21 (Crawled : 13:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: -1.49%
H: 8.33%
C: 6.82%
conference therapeutics
CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-07 (Crawled : 21:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 0.78%
H: 2.33%
C: -3.1%
business update therapeutics financial results
CytomX Therapeutics to Present at Upcoming November Investor Conferences
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: -0.91%
H: 2.75%
C: -0.92%
therapeutics
CytomX Therapeutics to Report Third Quarter 2023 Financial Results on November 7, 2023
Published: 2023-10-31 (Crawled : 12:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: -1.8%
H: 3.67%
C: 0.92%
report therapeutics financial results
CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b at the SITC 2023 Annual Meeting
Published: 2023-10-30 (Crawled : 12:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 2.8%
H: 3.64%
C: 0.91%
preclinical meeting therapeutics
CytomX Therapeutics Presents Preclinical Profile of EpCAM-directed Antibody Drug Conjugate CX-2051 at 2023 World ADC Conference
Published: 2023-10-18 (Crawled : 21:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 0.75%
H: 4.44%
C: -0.74%
cx-2051 drug conference antibody world preclinical therapeutics
CytomX Therapeutics to Present at Upcoming September Investor Conferences
Published: 2023-09-05 (Crawled : 20:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: -4.17%
therapeutics
CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference
Published: 2023-08-10 (Crawled : 20:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: -2.34%
H: 2.99%
C: 0.6%
conference cell therapeutics
CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-08 (Crawled : 20:00) - globenewswire.com
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: 0.0%
H: 0.59%
C: -3.55%
business update therapeutics financial results
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
ILAG | $0.51 6.03% 29.06% 430K
|
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.